Beda Islas-muñoz - Infectious Diseases

Author Information

Beda Islas-Muñoz is affiliated with the Infectious Diseases Department at the Instituto Nacional de Cancerología (INCan), located in Mexico City, Mexico. Their work primarily revolves around infectious diseases, particularly in the context of oncology and immunocompromised patients. This affiliation highlights their significant role in integrating infectious disease management within a cancer treatment framework, reflecting their expertise in both fields.

Research Contributions

Beda Islas-Muñoz has made significant contributions to the understanding of infectious diseases in cancer patients and those with compromised immune systems. Their research includes studies on the effects of valganciclovir on NK and NKT cell subpopulations in Kaposi Sarcoma patients, the clinical characteristics and outcomes of oncologic patients with COVID-19, and the diagnosis of opportunistic diseases in AIDS patients with disseminated Kaposi Sarcoma. Other notable work includes addressing complications such as cellulitis in HIV-related Kaposi Sarcoma and examining the implications of HIV-associated multicentric Castleman disease. Their research is pivotal in improving clinical outcomes and treatment strategies in these vulnerable patient populations.

Aliases

Beda Islas-Muñoz is also known by several variations of their name, including B Islas-muñoz and B. Islas-muñoz. These aliases are used interchangeably in various publications and academic references.

Publication and Citation Metrics

Metric	Value
Citation Count	87
h-index	3
Paper Count	13

Publications:

Valganciclovir as Add-On Therapy Modifies the Frequency of NK and NKT Cell Subpopulations in Disseminated Kaposi Sarcoma Patients

DOI: 10.3390/cancers14020412

Year: 2022

Clinical characteristics and outcomes in a cohort of oncologic patients with COVID‐19 during the first year of the pandemic in Mexico

DOI: 10.1002/cam4.4582

Year: 2022

295. SARS-CoV-2 Infection in a Referral Cancer Center in Mexico City During the First Year of the COVID-19 Pandemic

DOI: 10.1093/ofid/ofab466.497

Year: 2021

Cellulitis in patients with chronic lower-limb lymphedema due to HIV-related Kaposi sarcoma

DOI: 10.1177/09564624211059359

Year: 2021

Bone Marrow Culture Yield for the Diagnosis of Opportunistic Diseases in Patients with AIDS and Disseminated Kaposi Sarcoma.

DOI: 10.2174/1570162x18666200603145640

Year: 2020

HIV-associated multicentric Castleman disease: a report of 19 cases at an oncology institution

DOI: 10.1177/0956462420905277

Year: 2020

Obstructive cholangiopathy patient caused by cytomegalovirus and Kaposi sarcoma in a person living with HIV and hepatitis C

DOI: 10.1177/0956462420943027

Year: 2020

Successive complications after anterior cervical fixation: pharyngoesophageal diverticulum, fistulization, and cervical spondylitis by Streptococcus milleri – case report and literature review

DOI: 10.1186/s13256-019-2037-4

Year: 2019

Bloodstream infections in cancer patients. Risk factors associated with mortality.

DOI: 10.1016/j.ijid.2018.03.022

Year: 2018

Can Aspirin Be Used for Fever Management?

How Can Food and Water Contamination be Prevented?

What is Genomics?

What is the National Institutes of Health (NIH)?

Which Infectious Diseases Can Be Transmitted?

How Does Immunotherapy Work?

How is HFMD Transmitted?

What is the Impact of Vaccinations on Public Health?

What Are the Treatment Options for Co-Infections?

Can Monogamous Relationships Prevent Non-Sexual Infectious Diseases?

Partnered Content Networks

Relevant Topics